本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aura Biosciences, Inc.

4.97
-0.5000-9.14%
盤後5.220.2500+5.03%16:27 EDT
成交量:21.08萬
成交額:108.10萬
市值:2.50億
市盈率:-2.84
高:5.64
開:5.54
低:4.94
收:5.47
資料載入中...
2025/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/02

重要事件披露

Form 8-K - Current report
2025/03/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/24

重要事件披露

Form 8-K - Current report
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities